CSI Market
Sign In | Register

Novo Nordisk A (NVO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NVO Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Novo Nordisk A finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) 0
Assets
Cash, Cash Equivalents Other3,257.22
Current Tax Assets Current0.00
Cash & Short-term Investments3,257.00
Accounts receivable0.00
Trade & Other Current Receivables (IFRS combined total)12,729.33
Inventories0.00
Other Current Assets24,080.36
Total Current Assets27,337.58
Equipment/Property/Plant Net33,914.16
Goodwill net3,064.51
Intangible Assets16,964.17
Deferred Tax Assets0.00
Other Assets, Noncurrent4,936.63
Total Assets86,217.05
Liabilities
Accounts Payable2,282.23
Short-term Debt0.00
Other Liabilities, Current0.00
Current Provisions0.00
Total Current Liabilities2,282.23
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI0.00
Noncurrent Provisions52,627.58
Total Liabilities54,909.81
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity31,307.24
Total Stockholder's Equity31,307.24
Liabilities & Stockholder's Equity86,217.05
4 historic quarters locked

Sign in to unlock the full Novo Nordisk A balance sheet history.

Sign In Create Free Account

About Novo Nordisk A S Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: February 4, 2026
  • Source: nvo-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000353278-26-000012

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.